Delhi HC permits Biocon, Mylan to sell 'biosimilar' cancer drug
New Delhi [India], Mar. 3 (ANI): The Delhi High Court on Friday gave a green signal to pharmaceutical companies Biocon and Mylan to manufacture and sell biosimilar drug Trastuzumab for early breast and metastatic gastric cancer.